000 | 01510 a2200373 4500 | ||
---|---|---|---|
005 | 20250515222303.0 | ||
264 | 0 | _c20100526 | |
008 | 201005s 0 0 eng d | ||
022 | _a0033-3549 | ||
024 | 7 |
_a10.1177/003335491012500319 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDavid, Stephanie | |
245 | 0 | 0 |
_aWyeth v Levine: implications for public health policy and practice. _h[electronic resource] |
260 |
_bPublic health reports (Washington, D.C. : 1974) _c |
||
300 |
_a494-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Legal Case | ||
650 | 0 | 4 |
_aConsumer Product Safety _xlegislation & jurisprudence |
650 | 0 | 4 |
_aDrug Industry _xlegislation & jurisprudence |
650 | 0 | 4 |
_aDrug Labeling _xlegislation & jurisprudence |
650 | 0 | 4 |
_aDrug and Narcotic Control _xlegislation & jurisprudence |
650 | 0 | 4 |
_aGangrene _xchemically induced |
650 | 0 | 4 |
_aHistamine H1 Antagonists _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInjections, Intravenous _xadverse effects |
650 | 0 | 4 | _aLiability, Legal |
650 | 0 | 4 |
_aPromethazine _xadministration & dosage |
650 | 0 | 4 | _aSupreme Court Decisions |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 |
_aUnited States Food and Drug Administration _xlegislation & jurisprudence |
650 | 0 | 4 | _aVermont |
700 | 1 | _aRosenbaum, Sara | |
773 | 0 |
_tPublic health reports (Washington, D.C. : 1974) _gvol. 125 _gno. 3 _gp. 494-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/003335491012500319 _zAvailable from publisher's website |
999 |
_c19789550 _d19789550 |